بدائل البحث:
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
inter decrease » linear decrease (توسيع البحث), water decreases (توسيع البحث), teer decrease (توسيع البحث)
year increase » linear increase (توسيع البحث), may increase (توسيع البحث)
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
inter decrease » linear decrease (توسيع البحث), water decreases (توسيع البحث), teer decrease (توسيع البحث)
year increase » linear increase (توسيع البحث), may increase (توسيع البحث)
-
20301
Image 1_The relationship between peptic ulcer and cardiovascular disease in elderly population: a study on mortality and disease development.tiff
منشور في 2025"…CVD was a risk factor for PU, but PU did not significantly increase CVD risk. A higher mortality risk was observed in older and male PU patients. …"
-
20302
Supplementary file 1_Does body weight support improve neural and biomechanical measures during treadmill gait in children with unilateral cerebral palsy?.docx
منشور في 2025"…Beta band EEG activation from 0% to 20% BWS showed a significant triple interaction increasing in the non-dominant and decreasing in the dominant hemisphere in TD, while increasing in both in CP. …"
-
20303
Image 1_The association of diabetic retinopathy and diabetic kidney disease in patients with type 2 diabetes mellitus: a prospective observational research study.jpeg
منشور في 2025"…For four T2DM subgroups, the proportion of qi–yin deficiency increased with decreasing DR severity, whereas the proportion of yin–yang deficiency increased with increasing DR severity. …"
-
20304
Image 2_The association of diabetic retinopathy and diabetic kidney disease in patients with type 2 diabetes mellitus: a prospective observational research study.jpeg
منشور في 2025"…For four T2DM subgroups, the proportion of qi–yin deficiency increased with decreasing DR severity, whereas the proportion of yin–yang deficiency increased with increasing DR severity. …"
-
20305
Table 2_The association of diabetic retinopathy and diabetic kidney disease in patients with type 2 diabetes mellitus: a prospective observational research study.xlsx
منشور في 2025"…For four T2DM subgroups, the proportion of qi–yin deficiency increased with decreasing DR severity, whereas the proportion of yin–yang deficiency increased with increasing DR severity. …"
-
20306
Table 3_The association of diabetic retinopathy and diabetic kidney disease in patients with type 2 diabetes mellitus: a prospective observational research study.xlsx
منشور في 2025"…For four T2DM subgroups, the proportion of qi–yin deficiency increased with decreasing DR severity, whereas the proportion of yin–yang deficiency increased with increasing DR severity. …"
-
20307
Data Sheet 1_The association of diabetic retinopathy and diabetic kidney disease in patients with type 2 diabetes mellitus: a prospective observational research study.pdf
منشور في 2025"…For four T2DM subgroups, the proportion of qi–yin deficiency increased with decreasing DR severity, whereas the proportion of yin–yang deficiency increased with increasing DR severity. …"
-
20308
Table 4_The association of diabetic retinopathy and diabetic kidney disease in patients with type 2 diabetes mellitus: a prospective observational research study.xlsx
منشور في 2025"…For four T2DM subgroups, the proportion of qi–yin deficiency increased with decreasing DR severity, whereas the proportion of yin–yang deficiency increased with increasing DR severity. …"
-
20309
Table 1_The association of diabetic retinopathy and diabetic kidney disease in patients with type 2 diabetes mellitus: a prospective observational research study.xlsx
منشور في 2025"…For four T2DM subgroups, the proportion of qi–yin deficiency increased with decreasing DR severity, whereas the proportion of yin–yang deficiency increased with increasing DR severity. …"
-
20310
Western blot antibody information.
منشور في 2025"…<i>PTGFR</i> and <i>JNK</i> mRNA levels, MMP9 and ADH7 protein levels increased significantly in AN-LSCs after 0.313 μg/mL travoprost treatment (p≤0.039), while NF-κB and ADH7 protein levels decreased significantly in LSCs using 0.313 μg/mL travoprost (p=0.039; p<0.001).…"
-
20311
Information on healthy and aniridia subjects.
منشور في 2025"…<i>PTGFR</i> and <i>JNK</i> mRNA levels, MMP9 and ADH7 protein levels increased significantly in AN-LSCs after 0.313 μg/mL travoprost treatment (p≤0.039), while NF-κB and ADH7 protein levels decreased significantly in LSCs using 0.313 μg/mL travoprost (p=0.039; p<0.001).…"
-
20312
qPCR primers information.
منشور في 2025"…<i>PTGFR</i> and <i>JNK</i> mRNA levels, MMP9 and ADH7 protein levels increased significantly in AN-LSCs after 0.313 μg/mL travoprost treatment (p≤0.039), while NF-κB and ADH7 protein levels decreased significantly in LSCs using 0.313 μg/mL travoprost (p=0.039; p<0.001).…"
-
20313
Data Sheet 1_Face-to-face” is not superior to “face-to-screen”: comparing effects of online and offline communication skills course in postgraduate medical students.docx
منشور في 2025"…</p>Results<p>Both the online and offline groups showed significant increases in PPOS scores after teaching, and the online group had a significant improvement in JSE scores. …"
-
20314
Bias risk assessment of included studies.
منشور في 2025"…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO<sub>2</sub> (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO<sub>2</sub> (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …"
-
20315
Forest plot for hs-CRP.
منشور في 2025"…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO<sub>2</sub> (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO<sub>2</sub> (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …"
-
20316
Forest plot for IL-6.
منشور في 2025"…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO<sub>2</sub> (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO<sub>2</sub> (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …"
-
20317
Antibodies used for flow cytometry.
منشور في 2025"…</p><p>Results</p><p>Flow cytometry analysis revealed a significantly higher apoptosis rate in AN-LSCs compared to LSCs (p < 0.0001). …"
-
20318
The incidence rate of adverse reactions.
منشور في 2025"…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO<sub>2</sub> (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO<sub>2</sub> (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …"
-
20319
The PRISMA study flowchart.
منشور في 2025"…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO<sub>2</sub> (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO<sub>2</sub> (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …"
-
20320
Forest plot for FEV1/FVC.
منشور في 2025"…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO<sub>2</sub> (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO<sub>2</sub> (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …"